Protein and peptides exert multiple biological actions in human body and
they have been identified as showing great promise for treatment of
various diseases and disorders. These macromolecules are
calledbiopharmaceuticals. Targeted and/or controlled delivery of these
biopharmaceuticals using nanomaterials like nanoparticles and Dendrimers
is an emerging field called nanobiopharmaceutics, and these products
are called nanobiopharmaceuticals.
Keine Kommentare:
Kommentar veröffentlichen